Suppr超能文献

淋巴结比率(LNR)可区分pN1a-b和pN2期III期结肠癌的预后。

Lymph Node Ratio (LNR) Discriminates Prognostication in pN1a-b and pN2 Stage-III Colon Cancer.

作者信息

Akkus Erman, Kayaalp Mehmet, Karaoğlan Beliz Bahar, Akyol Cihangir, Utkan Güngör

机构信息

Ankara University Faculty of Medicine, Department of Medical Oncology, Ankara, Türkiye.

Ankara University Cancer Research Institute, Ankara, Türkiye.

出版信息

J Cancer. 2025 Jan 1;16(4):1032-1039. doi: 10.7150/jca.104336. eCollection 2025.

Abstract

The lymph node ratio (LNR), involved nodes/ lymph nodes examined, is associated with survival in colon cancer. Previous studies investigated the prognostic role of LNR regardless of TNM N staging or compared LNR and TNM N stages for prognostic strength. However, LNR may be utilized to obtain additional prognostic information rather than replacing TNM staging in daily practice. This study aimed to evaluate the role of LNR in TNM N stages to provide further prognostic information in daily practice. Patients with stage-III colon cancer who underwent surgery and adjuvant chemotherapy were included. pN1c tumors (tumor deposits without node involvement) and rectal cancers were excluded. Clinicopathological parameters and LNR in pN1a-b and pN2 groups were evaluated for recurrence-free survival (RFS). A total of 97 patients were included [pN1a-b: n=69 (71.1%) and pN2: n=28 (28.9%)]. Median LNR in the entire population was 0.09 (0.01-0.84) with a median lymph node examined of 22 (8-89) and involved of 2 (1-17). Median RFS was not reached in the pN1a-b and pN2 groups during a median follow-up of 20.8 months (1.13-101.03), with significantly better survival of the pN1a-b group (p=0.003). Among the pN1a-b group, the LNR cut-off was set as 0.10. LNR significantly discriminated RFS (Median not-reached, p=0.001). Among the pN2 group, the LNR cut-off was set as 0.25 and LNR significantly discriminated RFS [Not reached vs. 11.40 months (95%CI: 3.57-16.83), p=0.004]. Combined pN-LNR groups revealed significant discrimination in RFS (p<0.001). RFS was not statistically different between pN2-LNR≤0.25 and pN1-LNR>0.10 groups (p=0.282). In multivariable analysis with clinicopathological parameters, only LNR was significant (p=0.023), whereas the pN stage did not remain significant (p=0.637). LNR adds further prognostication in pN1a-b and N2 groups. LNR may be utilized to detect patient subgroups in different TNM N sages (pN1a-b and pN2) but with similar prognoses. This further prognostic information may assist clinical decisions in practice. The results of this study emphasize an adequate and higher number of lymph node samples in surgery.

摘要

淋巴结比率(LNR),即受累淋巴结数/检查的淋巴结数,与结肠癌的生存率相关。既往研究探讨了LNR的预后作用,而未考虑TNM N分期,或比较了LNR和TNM N分期的预后强度。然而,在日常实践中,LNR可用于获取额外的预后信息,而非取代TNM分期。本研究旨在评估LNR在TNM N分期中的作用,以在日常实践中提供进一步的预后信息。纳入接受手术及辅助化疗的III期结肠癌患者。排除pN1c肿瘤(无淋巴结受累的肿瘤结节)和直肠癌。评估pN1a-b和pN2组的临床病理参数及LNR,以分析无复发生存期(RFS)。共纳入97例患者[pN1a-b:n = 69(71.1%),pN2:n = 28(28.9%)]。总体人群的中位LNR为0.09(0.01 - 0.84),中位检查淋巴结数为22个(8 - 89个),受累淋巴结数为2个(1 - 17个)。在中位随访20.8个月(1.13 - 101.0)期间,pN1a-b组和pN2组均未达到中位RFS,pN1a-b组生存率显著更高(p = 0.003)。在pN1a-b组中,LNR临界值设定为0.10。LNR对RFS有显著区分作用(中位值未达到,p = 0.001)。在pN2组中,LNR临界值设定为0.25,LNR对RFS有显著区分作用[未达到 vs. 11.40个月(95%CI:3.57 - 16.83),p = 0.004]。联合pN - LNR组在RFS方面有显著区分(p < 0.001)。pN2 - LNR≤0.25组和pN1 - LNR>0.10组之间的RFS无统计学差异(p = 0.282)。在对临床病理参数进行多变量分析时,仅LNR具有显著性(p = 0.023),而pN分期不再具有显著性(p = 0.637)。LNR在pN1a-b和N2组中增加了进一步的预后评估。LNR可用于在不同TNM N分期(pN1a-b和pN2)但预后相似的患者中检测亚组。这一额外的预后信息可能有助于临床实践中的决策。本研究结果强调手术中应获取足够数量且更多的淋巴结样本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d4/11786040/9d8fbdbeb82f/jcav16p1032g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验